In vitro Generation of Cytotoxic T Cells With Potential for Adoptive Tumor Immunotherapy of Multiple Myeloma
Multiple myeloma is a life-threatening hematological malignancy, which is rarely curable by conventional therapies. Immunotherapy, using tumor antigen-specific, cytotoxic T-lymphocytes, may represent an alternative or additional treatment for multiple myeloma. In this study, we used hybrid cell line...
Main Authors: | Wafaa S. Khalaf, Mamta Garg, Yehia S. Mohamed, Cordula M. Stover, Michael J. Browning |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-08-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2019.01792/full |
Similar Items
-
Dendritic Cell-Based Immunotherapy in Multiple Myeloma: Challenges, Opportunities, and Future Directions
by: Emma Verheye, et al.
Published: (2022-01-01) -
Immunotherapy for the treatment of multiple myeloma
by: Leora S. Boussi, et al.
Published: (2022-10-01) -
The Role of Immunotherapy in Multiple Myeloma
by: Mehmet Kocoglu, et al.
Published: (2016-01-01) -
Exploring cellular immunotherapy platforms in multiple myeloma
by: Manh-Cuong Vo, et al.
Published: (2024-03-01) -
Cytotoxicity of WT1-reactive T cells against Wilms tumor: An implication for antigen-specific adoptive immunotherapy
by: Seyed Mostafa Monzavi, et al.
Published: (2023-09-01)